Association between Fecal Calprotectin and Mucosal Healing in Pediatric Patients with Crohn's Disease Who Have Achieved Sustained Clinical Remission with Anti-Tumor Necrosis Factor Agents
CONCLUSIONS: FC was associated with MH in pediatric patients with CD who had achieved a sustained CR for at least 6 months with anti-TNF agents. In these patients, FC can be used to stratify patients and guide decisions regarding ileocolonoscopy in the treat-to-target era.PMID:33833135 | DOI:10.5009/gnl20300
Source: Gut and Liver - Category: Gastroenterology Authors: Yoo Min Lee Sujin Choi Byung-Ho Choe Hyo-Jeong Jang Seung Kim Hong Koh Eun Sil Kim Mi Jin Kim Yon Ho Choe Ben Kang Source Type: research
More News: Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Liver | Lower Endoscopy | Pediatrics | Study | Urology & Nephrology